Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Tumor-induced hypophosphatemic osteomalacia: description of 2 cases.

Alvarez-Rivas N, Vazquez-Rodriguez TR, Garcia-Porrua C.

Med Clin (Barc). 2018 May 15. pii: S0025-7753(18)30250-1. doi: 10.1016/j.medcli.2018.04.010. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29776656
2.

Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients.

Alvarez Rivas N, Vazquez Rodriguez TR, Miranda Filloy JA, Garcia-Porrua C, Sanchez-Andrade Fernández A.

Reumatol Clin. 2017 May 25. pii: S1699-258X(17)30098-0. doi: 10.1016/j.reuma.2017.04.007. [Epub ahead of print] English, Spanish.

3.

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán JV, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C.

Clin Exp Rheumatol. 2017 May-Jun;35(3):423-430. Epub 2016 Dec 28.

PMID:
28032846
4.

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.

Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ.

Rheumatology (Oxford). 2016 Jul;55(7):1243-50. doi: 10.1093/rheumatology/kew049. Epub 2016 Mar 27.

PMID:
27018057
5.

Investigations into audiovestibular manifestations in patients with psoriatic arthritis.

Amor-Dorado JC, Barreira-Fernandez MP, Pina T, Vázquez-Rodríguez TR, Llorca J, González-Gay MA.

J Rheumatol. 2014 Oct;41(10):2018-26. doi: 10.3899/jrheum.140559. Epub 2014 Sep 1.

PMID:
25179845
6.

Ischiofemoral impingement: hip pain of infrequent cause.

López-Sánchez MC, Armesto Pérez V, Montero Furelos LÁ, Vázquez-Rodríguez TR, Calvo Arrojo G, Díaz Román TM.

Reumatol Clin. 2013 May-Jun;9(3):186-7. doi: 10.1016/j.reuma.2012.06.005. Epub 2012 Sep 25. English, Spanish.

7.

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gomez-Acebo I, Testa A, Garcia-Porrua C, Sanchez-Andrade A, Llorca J, González-Gay MA.

Mediators Inflamm. 2012;2012:674265. doi: 10.1155/2012/674265. Epub 2012 Jul 31.

8.

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.

Baerlecken NT, Linnemann A, Gross WL, Moosig F, Vazquez-Rodriguez TR, Gonzalez-Gay MA, Martin J, Kötter I, Henes JC, Melchers I, Vaith P, Schmidt RE, Witte T.

Ann Rheum Dis. 2012 Jun;71(6):943-7. doi: 10.1136/annrheumdis-2011-200413. Epub 2012 Jan 5.

PMID:
22228484
9.

Tuberculous spondylodiskitis with lumbar tumor.

López-Sánchez MC, Calvo Arrojo G, Vázquez-Rodríguez TR.

Reumatol Clin. 2012 Sep-Oct;8(5):292-3. Epub 2011 Dec 30. No abstract available.

10.

Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Miranda-Filloy JA, Perez-Esteban S, Vazquez-Rodriguez TR, Castañeda S, Balsa A, Fernández-Gutierrez B, Llorca J, González-Alvaro I, Martín J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):681-8. Epub 2011 Aug 31.

PMID:
21906432
11.

Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study.

Alonso MD, Llorca J, Martinez-Vazquez F, Miranda-Filloy JA, Diaz de Teran T, Dierssen T, Vazquez-Rodriguez TR, Gomez-Acebo I, Blanco R, Gonzalez-Gay MA.

Medicine (Baltimore). 2011 Sep;90(5):350-8. doi: 10.1097/MD.0b013e31822edf7f.

12.

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.

Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA.

Arthritis Res Ther. 2011 Aug 16;13(4):R133. doi: 10.1186/ar3444.

13.

Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain.

Martinez-Lado L, Calviño-Díaz C, Piñeiro A, Dierssen T, Vazquez-Rodriguez TR, Miranda-Filloy JA, Lopez-Diaz MJ, Blanco R, Llorca J, Gonzalez-Gay MA.

Medicine (Baltimore). 2011 May;90(3):186-93. doi: 10.1097/MD.0b013e31821c4fad.

14.

TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.

Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA.

Atherosclerosis. 2011 May;216(1):125-30. doi: 10.1016/j.atherosclerosis.2010.10.052. Epub 2011 Feb 24.

PMID:
21420089
15.

Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martín J, González-Gay MA.

Tissue Antigens. 2011 Apr;77(4):291-7. doi: 10.1111/j.1399-0039.2010.01625.x.

PMID:
21388351
16.

Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum.

Amoli MM, Miranda-Filloy JA, Vazquez-Rodriguez TR, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S131-2. Epub 2011 May 11. No abstract available.

PMID:
21385549
17.

Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martin J, González-Gay MA.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):293-8. Epub 2011 Apr 19.

PMID:
21385539
18.

Audiovestibular manifestations in patients with ankylosing spondylitis.

Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Diaz de Teran T, Llorca J, Gonzalez-Gay MA.

Medicine (Baltimore). 2011 Mar;90(2):99-109. doi: 10.1097/MD.0b013e3182079866.

19.

Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients.

Rodriguez-Rodriguez L, Garcia-Bermudez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1):19-25. Epub 2011 Feb 23.

PMID:
21345288
20.

Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.

Rodríguez-Rodríguez L, García-Bermúdez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1):142-3. Epub 2011 Feb 23. No abstract available.

PMID:
21269581
21.

Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Gómez-Vaquero C, Marí-Alfonso B, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Vicente EF, Blanco R, Amigo-Diaz E, Fernández-Gutiérrez B, Martin J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S12-6. Epub 2011 May 11.

PMID:
21269573
22.

Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis.

Amor-Dorado JC, Barreira-Fernández MP, Vázquez-Rodríguez TR, Miranda-Filloy JA, Llorca J, González-Gay MA.

Otol Neurotol. 2011 Feb;32(2):278-83. doi: 10.1097/MAO.0b013e3182016534.

PMID:
21150686
23.

Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients.

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, González-Gay MA.

Tissue Antigens. 2011 Jan;77(1):74-8. doi: 10.1111/j.1399-0039.2010.01580.x. Epub 2010 Nov 14.

PMID:
21073447
24.

Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.

Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5):695-701. Epub 2010 Oct 22.

PMID:
20822712
25.

Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Ortego-Centeno N, Narvaez J, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Nov;37(11):2331-3. doi: 10.3899/jrheum.100388. Epub 2010 Sep 1.

PMID:
20810507
26.

Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Oct;37(10):2076-80. doi: 10.3899/jrheum.100362. Epub 2010 Aug 3.

PMID:
20682661
27.

Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum.

Amoli MM, Miranda-Filloy JA, Vazquez-Rodriguez TR, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):115-6. No abstract available.

PMID:
20412719
28.

IL-18 gene polymorphisms in Henoch-Schönlein purpura.

Torres O, Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):114. No abstract available.

PMID:
20412718
29.

Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schönlein purpura.

Torres O, Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):110. No abstract available.

PMID:
20412715
30.

Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Gamallo C, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernadez-Gutierrez B, Castañeda S, Morado IC, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):40-5.

PMID:
20412701
31.

Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Castañeda S, Vazquez-Rodriguez TR, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Vicente EF, Ortego-Centeno N, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jul;37(7):1502-4. doi: 10.3899/jrheum.100016. Epub 2010 May 15.

PMID:
20472928
32.

A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis.

Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA.

Arthritis Res Ther. 2010;12(2):R71. doi: 10.1186/ar2989. Epub 2010 Apr 26.

33.

Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J.

Ann N Y Acad Sci. 2010 Apr;1193:153-9. doi: 10.1111/j.1749-6632.2009.05287.x. Review.

PMID:
20398022
34.

Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.

Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Torres O, Miranda-Filloy JA, Llorca J, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):68-72.

PMID:
20346241
35.

Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.

Gonzalez-Gay MA, Vazquez-Rodriguez TR, Garcia-Unzueta MT, Berja A, Miranda-Filloy JA, de Matias JM, Gonzalez-Juanatey C, Llorca J.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):56-62.

PMID:
20346239
36.

Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis.

Palomino-Morales RJ, Vazquez-Rodriguez TR, Torres O, Morado IC, Castañeda S, Miranda-Filloy JA, Callejas-Rubio JL, Fernandez-Gutierrez B, Gonzalez-Gay MA, Martin J.

Arthritis Res Ther. 2010;12(2):R51. doi: 10.1186/ar2962. Epub 2010 Mar 23.

37.

Lack of association between the rs6920220 (G/A) polymorphism of the 6q23 region and biopsy-proven giant cell arteritis.

Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 May;37(5):1020-3. doi: 10.3899/jrheum.091142. Epub 2010 Mar 15.

PMID:
20231195
38.

Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Ortego-Centeno N, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

Hum Immunol. 2010 May;71(5):525-9. doi: 10.1016/j.humimm.2010.02.016. Epub 2010 Mar 7.

PMID:
20156505
39.

Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis.

Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):964-70.

PMID:
20149313
40.

Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum.

Amoli MM, Miranda-Filloy JA, Vazquez-Rodriguez TR, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S142-3. No abstract available.

PMID:
19646363
41.

The use of carotid ultrasonography in the assessment of subclinical atherosclerosis and the paradoxical effect of corticosteroids on atherosclerosis in patients with rheumatoid arthritis.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Llorca J.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S141; author reply S141. No abstract available.

PMID:
19646362
42.

Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Ortego-Centeno N, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jan;37(1):131-5. doi: 10.3899/jrheum.090646. Epub 2009 Nov 16.

PMID:
19918040
43.

Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Valero F, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jan;37(1):136-40. doi: 10.3899/jrheum.090744. Epub 2009 Nov 16.

PMID:
19918036
44.

The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.

Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA.

Medicine (Baltimore). 2009 Nov;88(6):358-65. doi: 10.1097/MD.0b013e3181c10773.

45.

Epidemiology of giant cell arteritis and polymyalgia rheumatica.

Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J.

Arthritis Rheum. 2009 Oct 15;61(10):1454-61. doi: 10.1002/art.24459. Review. No abstract available.

46.

Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gonzalez-Juanatey C, de Matias JM, Martin J, Dessein PH, Llorca J.

Clin Exp Rheumatol. 2009 May-Jun;27(3):452-8.

PMID:
19604438
47.

Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.

Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Triñanes MC, Miranda-Filloy JA, Blanco R, Dierssen T, Gonzalez-Juanatey C, Llorca J.

Medicine (Baltimore). 2009 Jul;88(4):227-35. doi: 10.1097/MD.0b013e3181af4518.

48.

Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.

Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Callejas-Rubio JL, Miranda-Filloy JA, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2009 Jul;36(7):1501-6. doi: 10.3899/jrheum.081286. Epub 2009 Jun 16.

PMID:
19531762
49.

Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Dierssen T, Llorca J.

Arthritis Rheum. 2009 Jun 15;61(6):856-7; author reply 857-8. doi: 10.1002/art.24584. No abstract available.

50.

Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, de Matias JM, Martin J, Dessein PH, Llorca J.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2):222-8.

PMID:
19473561

Supplemental Content

Loading ...
Support Center